Researchers at the University of Cambridge have used artificial intelligence to design a broad-spectrum bird flu vaccine that they say protects against a wide range of virus variants in a single shot and could protect against strains that have not yet emerged.
Writing in Cell Reports Medicine, the team said the vaccine is part of a new generation of vaccines that target multiple strains of the same virus, with the aim of better preparing for future health emergencies, including those involving currently unknown threats. The authors described such vaccines as a game changer for national biosecurity and more resilient public health systems.
Bird flu is an RNA virus, like the coronaviruses that caused COVID-19, and can mutate rapidly into new strains that can jump from animals to humans and evade immune systems, as well as the protection offered by existing vaccines. Current pandemic preparedness relies on stockpiling vaccines against individual virus variants that have already emerged.
The researchers collected genetic sequence data from bird flu viruses recorded by surveillance programmes worldwide, including samples from wildlife, livestock and humans infected with bird flu. Using computational and evolutionary algorithms, they designed five AI-optimised synthetic antigens representing the global diversity of bird flu viruses. The antigen is the active ingredient in a vaccine that triggers the body’s immune system to produce a protective response.
In the study, the vaccine completely protected mice and ferrets against a range of genetically distinct variants of the virus that causes bird flu, all of which have caused human infections and represent potential pandemic threats. By comparison, only half the animals survived exposure to the same viruses when immunised with the World Health Organization’s existing bird flu vaccine.
Jonathan Heeney, from the Lab of Viral Zoonotics at the University of Cambridge, who led the work, said: “Rather than providing immunity to a single variant of bird flu, our new broad-spectrum vaccine is protective against a huge range of variants.” “It’s designed to anticipate viral evolution, rather than reacting to it,” he added.
Heeney said it was possible to be prepared to respond immediately to virus epidemics and pandemics, rather than always being on the back foot and responding with a strain that will have changed. “Using AI vastly speeds up the process of vaccine design, and then we can test the vaccine candidates in the lab to make sure they’re robust and safe,” he said.
The next step is to test the vaccine in human clinical trials, to make it available in the event of an outbreak and to expand the framework to seasonal influenza vaccines and other rapidly evolving RNA viruses. The vaccine was developed by the University of Cambridge and its company DIOSynVax Ltd.
Analysis
Why This Matters
- A broad-spectrum shot would let health authorities respond to an outbreak immediately rather than relying on stockpiles of vaccines built for individual strains that have already emerged.
- Bird flu is an RNA virus that mutates rapidly and can jump from animals to humans, so a vaccine designed to anticipate viral evolution could reduce the risk that a new variant evades existing protection.
- The same AI-driven framework is intended to extend to seasonal influenza vaccines and other fast-evolving RNA viruses, pointing to broader pandemic preparedness.
Background
Most flu vaccines are designed against a specific strain, which can be overtaken by viral change before or during an outbreak. The Cambridge team instead used global genetic sequence data to design synthetic antigens meant to represent the diversity of bird flu viruses. The vaccine has so far been tested only in mice and ferrets; human clinical trials are the stated next step.
What to Watch
- Whether human clinical trials begin and whether the vaccine’s protection holds outside animal studies.
- Whether surveillance programmes continue to supply sequence data from wildlife, livestock and humans to inform the AI-designed antigens.
- Whether the vaccine is made available for use in an outbreak and the framework is expanded to seasonal influenza.
Checked
12 claims in this story checked against 1 source: 12 supported.
Show each claim
- SupportedCambridge scientists used AI to design a broad-spectrum bird flu vaccine.Euronews: “Scientists at Cambridge University have developed a new vaccine using Artificial Intelligence that targets multiple strains of bird flu in one shot, rather than providing immunity to one variant.”
- SupportedThe vaccine could protect against multiple strains, including variants that have not yet emerged.Euronews: “The jab could protect even from variants that haven’t emerged yet, they say.”
- SupportedHeeney said the vaccine is protective against a huge range of variants, rather than providing immunity to a single variant.Euronews: ““Rather than providing immunity to a single variant of bird flu, our new broad-spectrum vaccine is protective against a huge range of variants,” said Jonathan Heeney”
- SupportedHeeney said the vaccine is designed to anticipate viral evolution rather than react to it.Euronews: ““It’s designed to anticipate viral evolution, rather than reacting to it,” he added.”
- SupportedThe authors described new-generation vaccines as a game changer for national biosecurity and more resilient public health systems.Euronews: “These new-generation vaccines are a game changer for national biosecurity and more resilient public health systems, the authors noted.”
- SupportedBird flu is an RNA virus that can mutate rapidly into strains that jump from animals to humans and evade immune systems and existing vaccines.Euronews: “RNA viruses represent a particular threat to human health because they can mutate rapidly into new strains that can jump from animals to humans and evade our immune systems — and the protection offered by existing vaccines.”
- SupportedResearchers collected bird flu genetic sequence data from worldwide surveillance programmes, including wildlife, livestock and infected humans.Euronews: “The researchers collected genetic sequence data from bird flu viruses recorded by surveillance programmes worldwide, including samples from wildlife, livestock and humans infected with bird flu.”
- SupportedThe researchers used computational and evolutionary algorithms to design five AI-optimised synthetic antigens representing bird flu’s global diversity.Euronews: “They used computational and evolutionary algorithms to design five AI-optimised synthetic antigens representing the global diversity of bird flu viruses”
- SupportedThe vaccine completely protected mice and ferrets against genetically distinct bird flu variants that had caused human infections and posed potential pandemic threats.Euronews: “In the new study, the vaccine completely protected mice and ferrets against a range of genetically distinct variants of the virus that causes bird flu — all of which have caused human infections and represent potential pandemic threats.”
- SupportedOnly half the animals survived exposure to the same viruses when immunised with the WHO’s existing bird flu vaccine.Euronews: “Only half the animals survived exposure to these same viruses when immunised with the World Health Organization's existing bird flu vaccine.”
- SupportedHeeney said AI greatly speeds up vaccine design and that candidates can then be tested in the lab for robustness and safety.Euronews: ““Using AI vastly speeds up the process of vaccine design, and then we can test the vaccine candidates in the lab to make sure they’re robust and safe,” said Heeney.”
- SupportedThe next step is human clinical trials, with the aim of making the vaccine available for an outbreak and expanding the framework to seasonal flu and other rapidly evolving RNA viruses.Euronews: “The next step is to test the new bird flu vaccine in human clinical trials, to make it available for use in the event of an outbreak and to expand the new framework to seasonal influenza vaccines and other rapidly evolving RNA viruses”